This page is not the official website. Generated by AI, does not constitute any advice. If needed, please click here to visit the corresponding official website.
Pioneering the future of in vitro research with IBAC® – the next-generation high-throughput, high-bionic platform combining organoids and organ-on-chip technologies.
Advanced in vitro models for drug screening, disease modeling, and personalized medicine.
Integrated Bionic Advanced Culture – high-throughput, biomimetic, scalable.
Pharmacology, toxicology, and basic research support using cutting-edge models.
We offer a comprehensive range of Organoids-on-Chips, chips, equipment, and kits designed for high-precision in vitro research and development.
All-in-one system for automated organoid culture and monitoring. Ideal for high-throughput screening and long-term studies.
3D microfluidic model mimicking human intestinal epithelium for absorption and toxicity testing.
High-fidelity liver model for drug metabolism and hepatotoxicity assessment.
Advanced blood-brain barrier model for CNS drug permeability and neurotoxicity studies.
Patient-derived tumor models for personalized oncology and immunotherapy testing.
Interconnected organ modules (liver, heart, kidney) for systemic toxicity and ADME studies.
Disposable microfluidic chips for single-organ culture with standardized protocols.
Complete kits including media, matrices, and protocols for specific organoid types.
Comprehensive technical support and custom solutions based on our innovative in vitro models.
High-throughput screening, efficacy testing, and preclinical safety assessment using human-relevant models.
Patient-derived organoids for personalized therapy selection and resistance mechanism studies.
Disease modeling, developmental biology, and host-microbe interaction studies.
We offer tailored experimental design, model development, and data analysis for academic and industry partners.
Our proprietary IBAC® platform combines the self-organizing capacity of organoids with the physiological relevance of organ-on-chip systems.
This next-generation in vitro model enables high-throughput, scalable, and highly biomimetic studies for drug discovery, disease modeling, and personalized medicine.
On April 12, 2022, Daxiang Biotech and Nikon signed a strategic cooperation agreement to jointly promote the development of organoid chip technology.
This partnership combines Nikon's advanced imaging solutions with our IBAC® platform to enable real-time, high-resolution monitoring of organoid dynamics.
Learn More About the CollaborationAs China's leader in Organoids-on-Chips technology, we are dedicated to revolutionizing in vitro research through innovative biomimetic models.
Founded with a mission to bridge the gap between traditional cell culture and animal models, our team of scientists and engineers has developed the IBAC® platform – a next-generation solution that combines the physiological relevance of organoids with the controllability of microfluidic systems.
We serve pharmaceutical companies, academic institutions, and research hospitals worldwide, providing both products and services that accelerate discovery and improve translational success.
Get in touch with our team for product inquiries, technical support, or collaboration opportunities.
(+86) 10-62370096
B2-336, Yiyuan Industrial Base, Haidian District, Beijing
For detailed product information, technical resources, and the latest news.
Go to daxiangbio.comNotice for Buyers: If you are a buyer, the above information is generated by AI collection and does not constitute any advice. If necessary, please visit the corresponding official website.
For Domain Owners: If you are the domain owner and do not want to be included by fobcompany.info, please contact [email protected] via your corporate email to cancel. We will cancel your inclusion within 3 business days.
如果您是域名所有者 不想被fobcompany.info收录 请用企业邮箱联系[email protected] 取消收录 我们将在3个工作日取消您的收录
Service Request: If you are other domain and want to be included, please contact [email protected]
如果您是其他域名合作 也请联系[email protected]